The patient, a 45-year-old female, with membranous glomerulonephropathy was treated with urokinase, dipyridamole, indomethacin, prednisolone or thiamphenicol individually. These all drugs except for indomethacin reduced urinary protein. Laboratory examinations showed a hypercoagulable state not only in the blood but also in the glomeruli.;
•Platelet function tests revealed increased adhesiveness and ADP aggregation. In thromboelasto-glam, k=2.75min, ma=63.0mm, ms=170.27%, r=6.0min
•Increased plasma antiplasmin activity was obserbed on fibrin plate.
•Immunohistologically a large amount of fibrin deposits were detected in the glomerular capillary lumens.
•The level of urinary FDP was 3μg/ml. It is said that the treatment with anticoagulants or fibrinolytic agents is not indicated for membranous glomerulonephropathy because of little connection with the blood coagulation mecha-nism on the course of its development. However, in this case with hypercoagulable state, both the therapies with anticoagulant or fibrinolytic agent (dipyridamole, urokinase) and other types of treatments (prednisolone, thiamphenicol) resulted in the decrease of urinary protein. These interesting findings indicate the multiplicity of factors which cause the renal damage and the variety of the treatments of glomerulonephritis and also offer a lot of suggestion to the disscussion on the blood coagulation system as one of the damaging factors in glomerulonephritis. At the same time these facts are significant and usefull when thinking about the indication of anticoagulant and/or fibrinolytic therapy.
View full abstract